Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT04408924 · COMPLETED
Trial details
- NCT number
- NCT04408924
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2022-04-27
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.